D & H India Share Price

India's economic growth to exceed 6.5% in FY26, says Moody's Ratings

Delhivery, Tata: Trading strategies in stocks that hit 52-week lows

Gensol Engineering shares plunge 50% in 12 days; rating downgrades weigh

Global funds' asset under custody see second-worst plunge amid market rout

Zydus Lifesciences to buy 86% stake in Amplitude Surgical for $280 million

Dear Sir Pursuant to Regulation 30 read with Schedule III Part A (A) and in compliance with Regulation 47(1)(b) of SEBI (LODR) Regulations 2015 regarding extract of Un-Audited Consolidated Financial Result for the Quarter/Nine month ended on 31.12.2022 was approved in Meeting of the Board of Director of the Company held on Thursday 2nd February 2023 at 1.00 P.M. at the Head Office of the Company at Indore. We herewith enclosed the newspaper advertisement published on 03.02.2023 in Free Press English edition and Nav Shakti Marathi edition.You are requested to please take on record our above said information for your reference and Record.

The Company has issued convertible 788000 warrant of Rs. 42/- convertible into equity shares of Rs. 10/- each at a premium of Rs. 32 per share. Out of which the Company has generated funds during the quarter ended 31st December 2022 as under;1. Upfront amount at the time of issuance of warrants on 12.10.2022 Rs. 82.74 Lakhs2. Conversion amount of First Trench for 388000 Warrants on 29.10.2022 Rs. 122.22 Lakhs.There is no modification in the project and the fund utilized against the actual funds raised for the quarter ended 31st December 2022 is enclosed herewith.

Dear Sir/Maam<BR> This has is in continuation with the previous notice dated 21st January 2023 given under Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 by which it was informed that a meeting No. 8/2022-23 of the Board of Directors of the Company is to be held on Thursday 2nd February 2023 at 1:00 P.M.<BR> <BR> We would like to inform that the Board of Directors at the aforesaid Board meeting have approved the following business and other regular items as per the agenda for the meeting:<BR> 1. The Board of Directors of the Company considered and approved the Un-audited Standalone and Consolidated Financial Results for the Quarter/nine month ended on 31st December 2022. <BR>

We would like to inform that the Board of Directors at the aforesaid Board meeting have approved the following business and other regular items as per the agenda for the meeting:1. The Board of Directors of the Company considered and approved the Un-audited Standalone and Consolidated Financial Results for the Quarter/nine month ended on 31st December 2022. The information and disclosure are being filed pursuant to Regulation 29 read with Regulation 30 of the SEBI (LODR) Regulations 2015.You are requested to please take on record our above said information for your reference and record and disseminate on the portal of the BSE for information to the investors and members of the Company.

D&H India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 inter alia to consider and approve Dear Sir/Madam Pursuant to Regulation 29(1)(a) of the SEBI (LODR) Regulations 2015 we are pleased to inform that Meeting of the Board of Directors of the Company is scheduled to be held on held on Thursday the 2nd day of February 2023. through Video Conferencing or Other Audio Visual Means (OAVM) for which purpose the Head Office of the Company situated at Plot A Sector A Industrial Area Sanwer Road Indore - 452015 (M.P.) shall be deemed as the venue for the Meeting to consider and approve the following business along with other routine businesses:1. To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter/nine months ended on 31st December 2022.We request you to please take on record our above said information for your reference and further needful.